B
United Therapeutics Corporation UTHR
$307.24 $1.850.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income 38.78% 15.51% 7.29% 27.27% 64.35%
Total Depreciation and Amortization 43.80% 43.61% 44.96% 12.78% 3.79%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 110.34% 86.53% 227.41% 328.79% -83.59%
Change in Net Operating Assets 95.42% -71.74% 39.32% -68.71% -4.44%
Cash from Operations 126.41% 8.95% 118.44% 0.45% 17.55%
Capital Expenditure -10.17% -16.44% -0.89% 7.51% -99.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -117.38% 84.50% 80.88% 530.20% 240.19%
Cash from Investing -392.64% 63.34% 64.79% 432.56% 122.24%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00% -- -- -- --
Issuance of Common Stock 250.68% 365.38% 110.93% -28.86% -86.85%
Repurchase of Common Stock -200.00% -100.00% -- -7,391.85% --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 0.00% --
Cash from Financing 19.50% -943.42% -294.33% -2,297.53% -267.21%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 43.30% 390.59% 208.32% -78.35% 1,885.71%
Weiss Ratings